Many tumors including prostate cancer are maintained by cancer stem cells (CSCs), which might cause tumor relapse if not eradicated during the course of treatment. Specific targeting or radiosensitization of CSCs bear promise to improve tumor curability by synergistic effects in combination with radiotherapy. Carbon nanotubes (CNTs) can be used as promising drug delivery systems for anticancer drugs such as the flavonoid catechin. Catechin is an extensively studied active ingredient of the different plants, including green tea, and it is widely recognized as co-adjuvant in cancer therapy. Here we describe the synthesis of biocompatible, catechin-loaded and gelatin-conjugated CNTs (Gel-CT-CNTs) with anticancer properties and demonstrate their potential for the eradication of prostate CSCs in combination with X-ray irradiation. Gel-CT-CNTs showed a significant enhancement of in vitro anticancer activity as compared to catechin alone. Moreover, treatment of prostate cancer cells with Gel-CT-CNT nanohybrids inhibited the tumorigenic cell population defined by a high aldehyde dehydrogenase (ALDH) activity. A combination of X-ray irradiation and treatment with Gel-CT-CNTs caused a decrease in the protein level of stem cell-related transcription factors and regulators including Nanog, Oct4 and β-catenin and led to an increase of cancer cell radiosensitivity as demonstrated by clonogenic and spherogenic cell survival assays. Taken together, our results suggest that a combination of irradiation and Gel-CT-CNTs can be potentially used for the radiosensitization and eradication of prostate CSC populations. What's new? In many cases, radiation successfully destroys a cancer, but it pops up again later thanks to cancer stem cells that survive the initial treatment. How to target these resilient cells before they strike again? Carbon nanotubes might be the ticket. These authors filled carbon nanotubes with catechin, which spurs apoptosis, and turned them loose on prostate cancer cells. The carbon-enclosed catechin killed more cells than catechin alone. When combined with X-ray irradiation, the catechin-filled nanotubes cut down the amount of stem-cell related transcription factors being produced, suggesting that these tiny marvels could help radiation treatment thwart cancer recurrence.

Development of novel radiochemotherapy approaches targeting prostate tumor progenitor cells using nanohybrids

Cirillo G.;
2015-01-01

Abstract

Many tumors including prostate cancer are maintained by cancer stem cells (CSCs), which might cause tumor relapse if not eradicated during the course of treatment. Specific targeting or radiosensitization of CSCs bear promise to improve tumor curability by synergistic effects in combination with radiotherapy. Carbon nanotubes (CNTs) can be used as promising drug delivery systems for anticancer drugs such as the flavonoid catechin. Catechin is an extensively studied active ingredient of the different plants, including green tea, and it is widely recognized as co-adjuvant in cancer therapy. Here we describe the synthesis of biocompatible, catechin-loaded and gelatin-conjugated CNTs (Gel-CT-CNTs) with anticancer properties and demonstrate their potential for the eradication of prostate CSCs in combination with X-ray irradiation. Gel-CT-CNTs showed a significant enhancement of in vitro anticancer activity as compared to catechin alone. Moreover, treatment of prostate cancer cells with Gel-CT-CNT nanohybrids inhibited the tumorigenic cell population defined by a high aldehyde dehydrogenase (ALDH) activity. A combination of X-ray irradiation and treatment with Gel-CT-CNTs caused a decrease in the protein level of stem cell-related transcription factors and regulators including Nanog, Oct4 and β-catenin and led to an increase of cancer cell radiosensitivity as demonstrated by clonogenic and spherogenic cell survival assays. Taken together, our results suggest that a combination of irradiation and Gel-CT-CNTs can be potentially used for the radiosensitization and eradication of prostate CSC populations. What's new? In many cases, radiation successfully destroys a cancer, but it pops up again later thanks to cancer stem cells that survive the initial treatment. How to target these resilient cells before they strike again? Carbon nanotubes might be the ticket. These authors filled carbon nanotubes with catechin, which spurs apoptosis, and turned them loose on prostate cancer cells. The carbon-enclosed catechin killed more cells than catechin alone. When combined with X-ray irradiation, the catechin-filled nanotubes cut down the amount of stem-cell related transcription factors being produced, suggesting that these tiny marvels could help radiation treatment thwart cancer recurrence.
2015
carbon nanotubes
catechin
radiosensitization
tumor-initiating cells
Aldehyde Dehydrogenase
Animals
Antineoplastic Agents
Catechin
Cell Line, Tumor
Cell Proliferation
Chemoradiotherapy
Drug Compounding
Gelatin
Gene Expression Regulation, Neoplastic
Humans
Male
Mice
Nanotubes, Carbon
Neoplasm Transplantation
Neoplastic Stem Cells
Prostatic Neoplasms
Radiation-Sensitizing Agents
File in questo prodotto:
Non ci sono file associati a questo prodotto.

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/20.500.11770/305657
 Attenzione

Attenzione! I dati visualizzati non sono stati sottoposti a validazione da parte dell'ateneo

Citazioni
  • ???jsp.display-item.citation.pmc??? ND
  • Scopus 32
  • ???jsp.display-item.citation.isi??? 30
social impact